Dong-A Socio Holdings Co., Ltd.

A000640

KR7000640003

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-22 EDT			5-day change	1st Jan Change
105,100 ^KRW	-0.57%		-2.59%	+4.06%

03-20	Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Dong-a Pharmaceutical Co. Ltd. authorizes a Buyback Plan.

March 19, 2020

The Board of Directors of Dong-a Pharmaceutical Co. Ltd. have authorized a buyback plan on March 20, 2020.

Latest news about Dong-A Socio Holdings Co., Ltd.

Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Dong-A ST Sets Sight on European Market with Stelara Biosimilar Expansion	23-08-31	MT
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Dong-A Socio Holdings Co., Ltd's Equity Buyback announced on October 26, 2022, has expired.	23-01-25	CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Dong-A Socio Holdings Co., Ltd. announces an Equity Buyback for 50,301 shares.	22-10-26	CI
Dong-A Socio Holdings Co., Ltd. authorizes a Buyback Plan.	22-10-25	CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Dong-A Socio Holdings Co., Ltd. agreed to acquire an additional 29.4% stake in DM Bio, Ltd. from Meiji Seika Pharma Co., Ltd for KRW 42.1 billion.	21-07-22	CI
Dong-A Socio Holdings Co., Ltd.(KOSE:A000640) dropped from KOSPI 200 Index	20-12-10	CI
Tranche Update on Dong-A Socio Holdings Co., Ltd.'s Equity Buyback Plan announced on March 20, 2020.	20-06-22	CI
Tranche Update on Dong-A Socio Holdings Co., Ltd.'s Equity Buyback Plan announced on March 20, 2020.	20-06-22	CI
Dong-A Socio Holdings Co., Ltd.'s Equity Buyback announced on March 20, 2020, has expired with 98,190 shares, representing 1.61% for KRW 8,384.55 million.	20-06-21	CI
Dong-A Socio Holdings Co., Ltd. announces an Equity Buyback for 140,000 shares.	20-03-20	CI
Dong-a Pharmaceutical Co. Ltd. authorizes a Buyback Plan.	20-03-19	CI
Meiji Seika Pharma Co., Ltd. and Dong-A Socio Holdings Co., Ltd. Announces the Initiation of A Phase I Clinical Trial of Dmb-3115	19-12-15	CI
INTAKE Co., Ltd. announced that it has received KRW 3.8 billion in funding from Dong-A Socio Holdings Co., Ltd., SOFTBANK Ventures Korea Inc.	18-02-01	CI
Dong-A Socio Holdings Co. Ltd. cancelled the acquisition of an additional stake in ST Pharm Co. Ltd..	17-08-22	CI
Dong-A Socio Holdings Co. Ltd. cancelled the acquisition of additional 10% stake in ST Pharm Co. Ltd. from Dong-A ST Co., Ltd..	16-12-23	CI
Dong-A Socio Holdings Co. Ltd. cancelled the sale of 49% stake in DMB Limited.	16-09-10	CI

Chart Dong-A Socio Holdings Co., Ltd.

Duration

Period

More charts

Dong-A Socio Holdings Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through five segments. The Medicine Manufacturing segment is engaged in the manufacture and sale of pharmaceuticals. The main pharmaceuticals include tonic medicines, cold medicines, raw material medicines. The Logistic segment is involved in the freight, courier, car transportation, freight warehousing and leasing business. The Packaging segment is engaged in manufacturing and sale of glass and glass products. The Holding Company segment is engaged in the provision of core companies and management consulting services. The Other segment is engaged in the production and sale of information and communication technology (IT) solutions and agricultural products, as well as real estate development business.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

105,100 KRW

Average target price

155,000 KRW

Spread / Average Target

+47.48%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DONG-A SOCIO HOLDINGS CO., LTD.	+4.06%	484M
ELI LILLY AND COMPANY	+38.69%	723B
NOVO NORDISK A/S	+34.28%	595B
JOHNSON & JOHNSON	-4.49%	369B
MERCK & CO., INC.	+20.24%	332B
ABBVIE INC.	+2.12%	282B
ASTRAZENECA PLC	+17.02%	244B
NOVARTIS AG	+9.31%	208B
ROCHE HOLDING AG	-5.07%	205B
PFIZER, INC.	-0.35%	168B

Other Pharmaceuticals

Dong-A Socio Holdings Co., Ltd.

Equities

A000640

KR7000640003

Pharmaceuticals

Dong-a Pharmaceutical Co. Ltd. authorizes a Buyback Plan.

Latest news about Dong-A Socio Holdings Co., Ltd.

Chart Dong-A Socio Holdings Co., Ltd.

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Pharmaceuticals